The TREM2-complement-amyloid signaling axis identified in Alzheimer's disease (where TREM2 activation on microglia promotes amyloid clearance via complement-mediated synaptic pruning regulation) shares structural homology with the protein aggregation pathology in the target unknown disease. Specifically, TREM2-mediated complement activation represents a conserved microglial mechanism for regulating protein aggregate clearance that may be transferable. In AD, loss-of-function TREM2 variants impai
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.55
Evidence
0.45
Novelty
0.65
Feasibility
0.00
Impact
0.00
Druggability
0.00
Safety
0.00
Competition
0.00
Data
0.00
Reproducible
0.00
KG Connect
0.53
Score Breakdown
Dimension
TREM2-complement-amyloid axis
Mechanistic
0.550
Evidence
0.450
Novelty
0.650
Feasibility
0.000
Impact
0.000
Druggability
0.000
Safety
0.000
Competition
0.000
Data
0.000
Reproducible
0.000
KG Connect
0.533
Evidence
TREM2-complement-amyloid axis as therapeutic target for prot